Literature DB >> 3141172

Evaluation of a new selective medium for Campylobacter pylori.

J C Dent1, C A McNulty.   

Abstract

Contaminating bacteria from the oropharynx and bacteria that colonise the stomachs of patients with a high gastric pH impede the isolation of Campylobacter pylori from gastric biopsy specimens. Commercially available selective supplements are inhibitory to this organism and therefore a specific selective medium is needed for isolation. Potential selective agents were evaluated for their activity against 97 strains of Campylobacter pylori. A modification of Skirrow's medium was developed; cefsulodin (5 mg/l) was substituted for polymyxin, and amphotericin B (5 mg/l) was added to inhibit Candida spp., a common contaminant of the stomach. No strains of Campylobacter pylori were inhibited by the Campylobacter pylori selective medium and it supported the growth of all strains compared with the biopsy urease test and Gram stained smear. Colonies were slightly larger and more easily recognised on the new medium compared with those grown on chocolate blood agar. This medium greatly improves the isolation of Campylobacter pylori and could be used alone, without a non-selective medium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141172     DOI: 10.1007/bf01962615

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  The estimation of the bactericidal power of the blood.

Authors:  A A Miles; S S Misra; J O Irwin
Journal:  J Hyg (Lond)       Date:  1938-11

2.  Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.

Authors:  C A McNulty; J Dent; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

3.  Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons.

Authors:  B S Drasar; M Shiner; G M McLeod
Journal:  Gastroenterology       Date:  1969-01       Impact factor: 22.682

4.  Stomach as source of bacteria colonising respiratory tract during artificial ventilation.

Authors:  S T Atherton; D J White
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

5.  Studies of the microaerophilic nature of Campylobacter fetus subsp. jejuni. I. Physiological aspects of enhanced aerotolerance.

Authors:  P S Hoffman; N R Krieg; R M Smibert
Journal:  Can J Microbiol       Date:  1979-01       Impact factor: 2.419

6.  Rapid identification of Campylobacter pylori (C. pyloridis) by preformed enzymes.

Authors:  C A McNulty; J C Dent
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

7.  Comparison of selective and nonselective media for recovery of Campylobacter pylori from antral biopsies.

Authors:  S Krajden; J Bohnen; J Anderson; J Kempston; M Fuksa; A Matlow; N Marcon; G Haber; P Kortan; M Karmali
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

8.  Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa.

Authors:  C S Goodwin; E D Blincow; J R Warren; T E Waters; C R Sanderson; L Easton
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

9.  Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment.

Authors:  R W Stockbrugger; P B Cotton; N Eugenides; B A Bartholomew; M J Hill; C L Walters
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

10.  The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.

Authors:  C S Goodwin; P Blake; E Blincow
Journal:  J Antimicrob Chemother       Date:  1986-03       Impact factor: 5.790

View more
  36 in total

Review 1.  ACP. Best practice no 154. February 1999. Helicobacter pylori.

Authors:  C A McNulty; J I Wyatt
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

2.  Culture of Helicobacter pylori from a gastric string may be an alternative to endoscopic biopsy.

Authors:  A L Samuels; H M Windsor; G Y Ho; L D Goodwin; B J Marshall
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Evaluation of two commercial enzyme immunoassays for the diagnosis of Helicobacter pylori infection.

Authors:  P M Aguirre; C Y Pascual; F J Merino; A C Velasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

4.  Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level.

Authors:  A H van Vliet; E J Kuipers; B Waidner; B J Davies; N de Vries; C W Penn; C M Vandenbroucke-Grauls; M Kist; S Bereswill; J G Kusters
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Rapid growth of Helicobacter pylori.

Authors:  T H Henriksen; O Brorson; R Schöyen; T Thoresen; D Setegn; T Madebo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

6.  Influence of contaminants on the isolation of Helicobacter pylori from gastric biopsy specimens.

Authors:  R Piccolomini; G Di Bonaventura
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

Review 7.  Diagnosis of Helicobacter pylori.

Authors:  U Blecker; D I Mehta
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

8.  New plate medium for growth and detection of urease activity of Helicobacter pylori.

Authors:  L Cellini; N Allocati; R Piccolomini; E Di Campli; B Dainelli
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

9.  Presence of Helicobacter pylori in the oral cavity, oesophagus, stomach and faeces of patients with gastritis.

Authors:  F Namavar; R Roosendaal; E J Kuipers; P de Groot; M W van der Bijl; A S Peña; J de Graaff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

10.  Enhanced cultivation of Helicobacter pylori in liquid media.

Authors:  H X Xia; L English; C T Keane; C A O'Morain
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.